Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China as Applied to Low-Value Imports

This presidential action amends previous orders to address the synthetic opioid crisis fueled by imports from China.

It eliminates the duty-free de minimis exemption for certain products from China, imposing either a 30% ad valorem or tiered specific duty on items valued under $800, depending on the method chosen by the transporter and enforced by the Department of Homeland Security's Customs and Border Protection (CBP).

The order requires carriers to remit duties to CBP and mandates a 90-day report assessing the action's impact on American industries.